Lariam,
Mefloquine,
Mefloquine Hydrochloride,
Mephloquine,
Ro 21 5998 001,
Ro-21-5998-001,
Ro215998001,
WR 142,490,
WR 177,602,
WR-142,490,
WR-177,602,
WR142,490,
WR177,602,
Mefloquine hydrochloride,
51773-92-3,
Mefloquine HCL,
Mephaquin,
Loriam,
Mefloquine (hydrochloride),
WR 142490 hydrochloride,
NSC 157387,
UNII-326VC85GV6,
Mefloquin Hydrochloride,
Ro 21-5998/001,
EINECS 257-412-0,
326VC85GV6,
DL-erythro-alpha-2-Piperidyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol monohydrochloride,
DSSTox_CID_27796,
DSSTox_RID_82568,
DSSTox_GSID_47819,
MLS001332559,
(AS)-rel-a-(2R)-2-Piperidinyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol monohydrochloride,
(R*,S*)-(1)-alpha-2-Piperidyl-2,8-bis(trifluoromethyl)quinoline-4-methanol monohydrochloride,
(S)-[2,8-bis(trifluoromethyl)quinolin-4-yl][(2R)-piperidin-2-yl]methanol hydrochloride,
4-Quinolinemethanol, alpha-(2R)-2-piperidinyl-2,8-bis(trifluoromethyl)-, monohydrochloride, (alphaS)-rel-,
4-Quinolinemethanol, alpha-2-piperidinyl-2,8-bis(trifluoromethyl)-, monohydrochloride, (R*,S*)-(+-)-,
CAS-51773-92-3,
NCGC00161831-02,
51742-86-0,
SMR000875233,
TCMDC-124288,
mefloquine-hcl,
Mefloquine hydrochloride, (+),
MFCD00797519,
Mefloquine hydrochloride [USAN],
NSC-157387,
GNF-Pf-5559,
AK-78309,
Lariam (TN),
Mefloquine hydrochloride [USAN:USP],
Mefloquinehydrochloride,
CHEMBL1606,
SCHEMBL41094,
C17H16F6N2O.HCl,
MLS001332560,
AC1L232A,
CHEBI:6719,
DTXSID1047819,
(+/-)-Mefloquine Hydrochloride,
KS-000015FZ,
Tox21_111999,
HY-17437A,
s4420,
Mefloquine hydrochloride (JP17/USP),
AKOS015919767,
Tox21_111999_1,
AC-4686,
CS-1430,
GS-3621,
NC00622,
NCGC00161831-04,
AN-11705,
BC202800,
BR-78309,
CPD000875233,
M637,
PC404546,
SAM002699894,
AB0015316,
AB1008604,
AX8016625,
LS-142001,
M2313,
SW220098-1,
Ro-21-5998/001,
D00831,
Mefloquine hydrochloride, >=98% (HPLC), powder,
Q-201345,
UNII-5Y9L3636O3 component WESWYMRNZNDGBX-YLCXCWDSSA-N,
Mefloquine hydrochloride, European Pharmacopoeia (EP) Reference Standard,
(|AS)-rel-|A-(2R)-2-Piperidinyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol,
(2,8-Bis-trifluoromethylquinolin-4-yl)-piperidin-2-yl-methanol hydrochloride(R*,S*),
(S)-[2,8-bis(trifluoromethyl)-4-quinolyl]-[(2R)-2-piperidyl]methanol hydrochloride,
(S)-[2,8-bis(trifluoromethyl)quinolin-4-yl]-[(2R)-piperidin-2-yl]methanol hydrochloride,
4-Quinolinemethanol,alpha-2-piperidinyl-2,8-bis(trifluoromethyl)-,(R*,S*)-(+-),
Mefloquine Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material,
Mefloquine hydrochloride, United States Pharmacopeia (USP) Reference Standard,
(AS)?-?rel-?a-?(2R)?-?2-?Piperidinyl-?2,8-?bis(trifluoromethyl)?-?4-?quinolinemethanol monohydrochloride,
4-Quinolinemethanol, 2,8-bis(trifluoromethyl)-alpha-2-piperidinyl-, monohydrochloride,(R*,S*)-, (+-)-,
4-Quinolinemethanol, a-(2R)-2-piperidinyl-2,8-bis(trifluoromethyl)-,monohydrochloride, (aS)-rel-,
4-Quinolinemethanol, alpha-2-piperidinyl-2,8-bis(trifluoromethyl)-, monohydrochloride, (R*,S*)- (+-)-,
Lariam,
mefloquine,
C17H16F6N2O.ClH,
UNII-5Y9L3636O3,
C17H16F6N2O,
TCMDC-123920,
CID65329,
C17-H16-F6-N2-O.Cl-H,
5Y9L3636O3,
WR 142490,
WR-142490,
A3593,
C(F)(F)(F)c1cccc2c1nc(cc2C(O)C3CCCCN3)C(F)(F)F,
(2R)-(+/-)-alpha-2-Piperidinyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol monohydrochloride,
(R*,S*)-(+-)-alpha-2-piperidyl-2,8-bis(trifluoromethyl)quinoline-4-methanol monohydrochloride,
4-Quinolinemethanol, .alpha.-2-piperidinyl-2,8-bis(trifluoromethyl)-, monohydrochloride, (R*,S*)-(.+.)-,
MQ,